Ireland 3D Imaging Market Analysis Report 2022 to 2030

Ireland 3D Imaging Market Analysis

$ 3999

Ireland's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. The market will be driven by increased demand for enhanced imaging modalities for diagnostic and therapeutic uses, as well as a growing emphasis on personalized treatment and precision healthcare. The market is segmented by product, application, end-user & by portability. Some of the major players include GE Healthcare, Siemens Healthineers & MedScan3D.

ID: IN10IEDH001 CATEGORY: Digital Health GEOGRAPHY: Ireland AUTHOR: Vidhi Upadhyay

Buy Now

Ireland 3D Imaging Market Executive Summary

Ireland's 3D imaging market is projected to grow from $xx Bn in 2022 to $xx Bn by 2030, registering a CAGR xx% during the forecast period of 2022-30. Out of the 33 OECD economies, Ireland ranks sixth in terms of government spending on healthcare as a proportion of national income. In 2020, Ireland is projected to spend 7.1% of its GDP on healthcare, up from 6.7% in 2019. Healthcare spending in Ireland has grown in recent years as a result of an aging population and rising medical treatment and prescription expenses. Despite this, the government has been working to reduce healthcare costs by implementing cost-cutting initiatives such as the launch of generic medicines and pharmaceutical reference pricing. According to National Cancer Registry Ireland (NCRI) statistics for 2018-2020, Every year, over 43,500 people in Ireland are diagnosed with cancer with Prostate, Breast & Lung cancers being the top three most diagnosed cancers.

Medical imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound, as well as advanced visualization software, are all part of Ireland's 3D Imaging industry. These technologies are utilized for a number of applications, including disease detection and monitoring, surgery planning, and the manufacturing of specialized implants and prostheses.

Market Dynamics

Market Growth Drivers

The rising frequency of chronic illnesses such as cancer and cardiovascular disease is one of the market's key drivers. The rising need for minimally invasive surgical treatments is another significant driver of the 3D Imaging market in Ireland. For guiding and visualization, these operations rely largely on modern imaging technology, particularly 3D Imaging technologies, which can produce extremely detailed, real-time images that are necessary for these treatments. Moreover, the growth of targeted therapy and individualized healthcare, as well as the increasing usage of advanced visualization software technologies, are also propelling the Irish 3D Imaging market. These factors are projected to continue to fuel market expansion in the future years.

Market Restraints

The high cost of modern imaging technology is one of the key market limitations. While these technologies are essential for the detection and treatment of many diseases, they are sometimes too expensive for certain patients and healthcare professionals. While the country has a well-developed medical device regulatory system, the licensing procedure can be time-consuming and complex. This makes it difficult for smaller firms with limited resources to bring novel imaging technologies to market, and it has the potential to hinder industry innovation.

Competitive Landscape

Key Players

GE Healthcare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
Fujifilm Holdings Corporation
Hitachi Healthcare
Sectra AB
MedScan3D (IRL)

Notable Deals

November 2022, Philips enhanced AI-powered diagnostic technologies and transformational workflow solutions at RSNA 2022
In October 2022, Philips revealed two significant advancements in MR-only procedures for head and neck cancer radiation imaging and simulation
In September 2022, GE Healthcare’s deep-learning 3D Imaging system received an FDA expanded approval. Also, it’s “AIR Recon DL” Received FDA Approval for 3D and Motion-Insensitive Imaging Applications for Superior Image Quality and Patient Experience in MRI

Healthcare Policies and Regulatory Landscape

The Health Products Regulatory Authority (HPRA) is Ireland's competent authority in charge of medical device regulation, including those used for 3D Imaging. The HPRA governs the safety, quality, and performance of medical devices, including 3D Imaging equipment. Furthermore, the Health Information and Quality Authority (HIQA) establishes rules and recommendations for healthcare practitioners, including those that employ 3D Imaging technology.

Reimbursement Scenario

The Health Service Executive is Ireland's government-financed healthcare system, in charge of providing health and personal social services. Eligible people can gain free access to a variety of medical services, including 3D Imaging, under the HSE's medical card system.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Ireland 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

X-ray Imaging Systems
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Ultrasound
Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

Cardiology
Neurology
Orthopedics
Gynecology
Oncology
Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

Hospitals
Diagnostic Imaging Centers
Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

Stationary
Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.